Valuation : Unichem Laboratories Limited

Market Cap 38.79B 411M 353M 333M 304M 568M 570M 3.93B 1.53B 19.9B 1.54B 1.51B 64.11B P/E 2025
35.6x
P/E 2026 8.19x
Enterprise Value 40.89B 433M 373M 351M 320M 599M 601M 4.14B 1.61B 20.98B 1.63B 1.59B 67.59B EV / Sales 2025
2.49x
EV / Sales 2026 1.03x
Free-Float
28.74%
Yield 2025 *
-
Yield 2026 -
1 day+0.41%
1 week-2.49%
Current month-1.14%
1 month+9.97%
3 months+47.70%
6 months+74.00%
Current year+24.52%
1 week 542.85
Extreme 542.85
589.35
1 month 482.3
Extreme 482.3
600
Current year 278.2
Extreme 278.2
687.2
1 year 278.2
Extreme 278.2
687.2
3 years 278.2
Extreme 278.2
937.95
5 years 198
Extreme 198
937.95
10 years 80
Extreme 80
937.95
Manager TitleAgeSince
Chief Executive Officer 57 09/08/2023
Director of Finance/CFO - 07/08/2024
Compliance Officer - -
Director TitleAgeSince
Chairman 73 21/08/1977
Director/Board Member 53 09/08/2023
Director/Board Member 57 09/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
+0.41%-2.49% - - 411M
-0.88%-2.15%+54.71%+106.31% 1,024B
-1.15%+2.68%+53.97%+71.50% 663B
-1.44%+0.38%+20.40%+73.05% 453B
+0.14%-0.47%+29.49%+38.56% 352B
-1.33%+4.72%+24.69%+45.55% 304B
-1.15%+0.30%-1.49%+12.31% 252B
-1.55%+1.11%+56.10%+70.32% 236B
-0.88%+1.15%-17.09%-54.39% 206B
-0.15%+3.65%+33.90%+96.99% 187B
Average -0.85%+1.09%+28.30%+51.13% 408.71B
Weighted average by Cap. -1.10%+0.55%+36.62%+66.22%

Financials

2025 2026
Net sales 21.11B 224M 192M 181M 165M 309M 310M 2.14B 830M 10.83B 840M 821M 34.89B 22.02B 233M 201M 189M 172M 323M 324M 2.23B 866M 11.3B 876M 857M 36.39B
Net income 1.38B 14.57M 12.53M 11.79M 10.77M 20.15M 20.21M 139M 54.07M 706M 54.69M 53.5M 2.27B 2.53B 26.78M 23.04M 21.68M 19.81M 37.05M 37.15M 256M 99.42M 1.3B 101M 98.37M 4.18B
Net Debt 3.7B 39.21M 33.74M 31.74M 29M 54.25M 54.39M 375M 146M 1.9B 147M 144M 6.12B 2.11B 22.31M 19.2M 18.06M 16.5M 30.87M 30.95M 213M 82.83M 1.08B 83.79M 81.96M 3.48B
Logo Unichem Laboratories Limited
Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.
Employees
2,780
Date Price Change Volume
04/09/26 ₹550.20 +0.41% 56,415
03/09/26 ₹547.95 -2.09% 73,499
02/09/26 ₹559.65 +0.59% 155,387
01/09/26 ₹556.35 -0.04% 192,598
31/08/26 ₹556.55 -1.36% 321,470